Attention-deficit/Hyperactivity Disorder in the Context of Autism Spectrum Disorders
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASD) are frequently marked by symptoms consistent with attention-deficit/hyperactivity disorder (ADHD), namely inattention, hyperactivity, and impulsivity. Recent work has established that about half of the ASD population also meets diagnostic criteria for ADHD, although the comorbid diagnoses are precluded by the DSM-IV-TR. Individuals with co-occurring ASD and ADHD symptoms are more severely impaired, with significant deficits seen in social processing, adaptive functioning, and executive control. Children with ASD and ADHD symptoms are also prone to motor problems, which lead to especially poor outcomes. Recent work has also demonstrated high rates of ASD symptoms in a subset of children with ADHD. Medication studies have demonstrated the efficacy of methylphenidate, atomoxetine, and guanfacine, among others, in treating ADHD symptoms co-occurring with ASD. However, these effects were not as great as those seen when treating primary ADHD, and they are less well-tolerated in the ASD population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A large proportion of autistic children meet criteria for ADHD (41%-78% (Murray, 2010).”
From Data‐driven identification of subtypes of executive function across typical development, attention deficit hyperactivity disorder, and autism spectrum disorders (2020) · cites this paper as Murray, 2010
In the citing paper
“Impulsivity and impaired inhibition, which are present in as many as 50% of children with ASD,26”
From Emotion Regulation (2014) · cites this paper as [26]
In the citing paper
“Atomoxetine, a nonstimulant medication that functions via norepinephrine and dopamine, has demonstrated better tolerability than stimulant medications in individuals with co-occurring ADHD and ASD [42].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [42]
In the citing paper
“Limited work has examined psychosocial interventions for co-occurring ADHD and ASD [42,65].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [42]
In the citing paper
“Interest in the co-occurrence of ADHD and ASD has grown tremendously in the last decade, with multiple published studies addressing questions of heritability and shared etiology [13,15,124], as well as common phenotypic and endophenotypic features [17,42].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [42]
Citations
Cites
Executive functions and developmental psychopathology.
Pennington, B. F., & Ozonoff, S. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01380.x · Cited by 3,150 · cited 1×
“They are key to maintaining effective goal-directed behavior [12].”
BackgroundRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · cited 1×
“The dopaminergic system has been implicated in motor dysfunction, ADHD, and autism [29].”
BackgroundHappé, F., Booth, R., Charlton, R., & Hughes, C. (2006) · Brain and Cognition · doi:10.1016/j.bandc.2006.03.004 · Cited by 638 · cited 1×
“This was in contrast to previous work that demonstrated children with ASD as having less severe EC deficits compared with children with ADHD [14].”
ResultKlin, A., Saulnier, C. A., Sparrow, S. S., Cicchetti, D. V., Volkmar, F. R., & Lord, C. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0229-4 · Cited by 585 · cited 1×
“Individuals with ASD show more severe impairments [15, 16].”
BackgroundCorbett, B. A., Constantine, L. J., Hendren, R., Rocke, D., & Ozonoff, S. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.02.005 · Cited by 584
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
Fine and gross motor ability in males with ADHD
Pitcher, T. M., Piek, J. P., & Hay, D. A. (2003) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2003.tb00952.x · Cited by 478
Dyspraxia in autism: association with motor, social, and communicative deficits
Dziuk, M. A., Larson, J. C. G., Apostu, A., Mahone, E. M., Denckla, M. B., & Mostofsky, S. H. (2007) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2007.00734.x · Cited by 464
Motor Signs Distinguish Children with High Functioning Autism and Asperger’s Syndrome from Controls
Jansiewicz, E. M., Goldberg, M. C., Newschaffer, C. J., Denckla, M. B., Landa, R., & Mostofsky, S. H. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0109-y · Cited by 429
Cited by
Leitner, Y. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00268 · Cited by 439
Mazefsky, C. A., & White, S. W. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.07.002 · Cited by 323
Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01600 · Cited by 274
Barchel, D., Stolar, O., De-Haan, T., Ziv-Baran, T., Saban, N., Fuchs, D. O., Koren, G., & Berkovitch, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01521 · Cited by 206
Use of psychotropic medication in children and adolescents with autism spectrum disorders
Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900d · Cited by 191
“4) 46 (4) 6–11 y (951) 422 (44) 119 (13) 60 (6) 247 (26) 111 (12) 136 (14) 129 (14) 12–17 y (276) 176 (64) 55 (20) 31 (11) 92 (33) 39 (14) 88 (32) 64 (23) Total 760 (27) 208 (7) 130 (5) 379 (13) 205 (7) 241 (8) 239 (8)”
Metadata
- Authors
- Murray, M. J.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Murray, Michael J.
- ORCID
- Murray, Michael J.
- Venue
- Current Psychiatry Reports
- Published
- 2010-08-07
- Volume
- 12
- Issue
- 5
- Pages
- 382-388
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- OpenAlex
- W1976380277
- Cited by
- 185
- References
- 48
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 19 · 2023: 22 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 12 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 13 · 2014: 13 · 2013: 17 · 2012: 15
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- autism spectrum disorder, attention deficit hyperactivity disorder, comorbidities, executive dysfunction, adaptive behavior, motor problems, methylphenidate, atomoxetine, guanfacine
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Child Development Disorders, Pervasive, Humans, Methylphenidate, Executive Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attention-deficit/Hyperactivity Disorder in the Context of Autism Spectrum Disorders. https://app.cochat.ai/papers/10.1007/s11920-010-0145-3
- The paper
- Murray, M. J. (2010). Attention-deficit/Hyperactivity Disorder in the Context of Autism Spectrum Disorders. Current Psychiatry Reports. https://doi.org/10.1007/s11920-010-0145-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.